SKYE
Skye Bioscience, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Skye Bioscience (SKYE) Stock: Buy, Sell, or Hold?
$1.09
+0.01 (+0.93%)
▲
5d:
+10.07%
30d:
-31.45%
90d:
+162.59%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
59/100
Position
OVERSOLD
30-Day Fair Range
$1.17 – $1.70
Position: OVERSOLD
Forward P/E & Valuation
-0.2x
Next 12M consensus est.
Wall Street Target
$68.00
+6138.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.50 / $1.36
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: SKYE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When SKYE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SKYE is currently trading at $1.09, which is considered oversold relative to its 30-day fair value range of $1.17 to $1.70.
Technical Outlook: Technically, SKYE is in a uptrend. Immediate support is located at $0.50, while resistance sits at $1.36.
Market Sentiment: SKYE scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $68.00 (+6138.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SKYE is in a uptrend. Immediate support is located at $0.50, while resistance sits at $1.36.
Market Sentiment: SKYE scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $68.00 (+6138.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.17 -
$1.70
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$1.17 -
$1.70
Current vs Trading Range
OVERSOLD
Support Level
$0.50
Resistance Level
$1.36
Current Trend
Uptrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 6138.5% below Wall St target ($68.00)
- CAUTION: Bottoming setup, but lagging the sector by 20% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-0.16
Wall Street Target
$68.00
(+6138.5%)
Share SKYE Analysis
Share this live SKYE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SKYE)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment prevails on StockTwits regarding $SKYE after announcement of reverse split.
Key Retail Themes:
Reversed split
Negative sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:53 PM ET
Data refreshes hourly during market hours. Next update: 6:53 PM
Data refreshes hourly during market hours. Next update: 6:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SKYE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 33 SELL |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 35 SELL |
|
ARDX
Ardelyx Inc |
STRONG BUY
11 analysts |
$13 | 69 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SKYE Research Pages
